Mr Mathias Winkler Consultant urologist
- Patient age group
- Consultant registered on
- Primary medical qualifications
- State Exam Med 1992 Medizinisch Akademie Magdeburg
- Foreign languages
- 020 3313 0046
2005 FRCS Urol, Intercollegiate Board Exam Urology
1999 - 2001 MD Bristol Urological Institute and University of Magdeburg: 'Radical prostatectomy in the South of England from 1989 to 2001'
Mr Mathias Winkler is an accredited consultant urologist and pelvic minimally invasive surgeon. He has a strong academic background in surgical pelvic oncology and a major interest in imaging biomarker development and prostate cancer biomarker validation. His special interests are in minimally-invasive treatments for prostate cancer and prostate imaging. He has made a lifetime commitment to excellence in medical education.
Mr Winkler is currently a consultant urologist, at Charing Cross Hospital and at West Middlesex University Hospital, London. He is also an adjunct reader in urology at Imperial College London. Other positions he currently holds include specialty programme director and chair of Training Programme Management Group, Urology for North London, Imperial Lead Provider; urology cancer lead in the department of urology, West Middlesex University Hospital, London since 2008; lead of prostate cancer SMDT at Imperial College NHS Healthcare Trust; and trustee and board director at The Mulberry Centre. He has also been lecturer for the graduate entry anatomy course since 2008.
Prostate cancer, urological infections, urinary symptoms
Research & publications
Alshaker, H., Krell, J., Frampton, A.E., Waxman, J., Blyuss, O., Zaikin, A., Winkler, M., et al. (2014) Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway. Breast Cancer Res, Oct 25, 16(5), 426
Dickinson, L., Ahmed, H.U., Kirkham, A.P., Allen, C., Freeman, A., Barber, J., Hindley, R.G., Leslie, T., Ogden, C., Persad, R., Winkler, M.H., Emberton, M. (2013) INDEX Study Group. A multi-centre prospective development study evaluating focal therapy using high-intensity focused ultrasound for localised prostate cancer: The INDEX study. Contemp Clin Trials, Sep, 36(1), 68-80
Dudderidge, T.J., Doyle, P., Mayer, E.K., Taylor, J., Agrawal, S., Stolzenburg, J.U., Winkler, M.H. (2012) Evolution of care pathway for laparoscopic radical prostatectomy. J Endourol, Jun, 26(6), 660-5
Faure Walker, N.A., Nir, D., Simmons, L., Agrawal, S., Chung, C., Leminski, A., Rashid, T., Shamsuddin, A., Winkler, M. (2015) Using imaging biomarkers to improve the planning of radical prostatectomies. Urol Oncol, Jan, 33(1), 17
Karavitakis, M., Winkler, M., Abel, P., Livni, N., Beckley, I., Ahmed, H.U. (2011) Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis, Mar, 14(1), 46-52